Thor Medical aktie (TRMED) | Pressmeddelande - Börskollen
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

•Investeringsmöjlighet: Bli delägare i global ledare inom AI-baserad videoanalys på säkerhetsmarknaden (annons)

Pressmeddelanden från Thor Medical

 Bevaka pressreleaser
StartNyheterPressreleaserRiktkurserInsynshandelBlankningAnalyserBloggarVideosPodcasts

Thor Medical ASA first half 2023 results

Oslo, 31 August 2023: In the first half 2023, Thor Medical ASA completed the close down of the PARADIGME study and reduced the burn to prese...

Cision • 31 Aug 2023 07:00

Invitation to presentation of Thor Medical ASA's first half results 2023

Oslo, 17 August 2023: Thor Medical ASA will release its first half results on Thursday 31 August 2023 at 07:00 am (CEST).

Cision • 17 Aug 2023 15:39

Nordic Nanovector – Completion of annual general meeting

Nordic Nanovector – Completion of annual general meeting

Cision • 28 Jun 2023 16:30

Disclosure of proxies for the AGM

The Chairman will vote for 10.606.127 shares (or 9,14%) and the Interim CEO & CFO will vote for 20.

Cision • 27 Jun 2023 14:45

Nordic Nanovector - Mandatory notification of trade - primary insider

Nordic Nanovector - Mandatory notification of trade - primary insider

Cision • 07 Jun 2023 14:46

Nordic Nanovector ASA: Results for the First Quarter 2022

Nordic Nanovector ASA: Results for the First Quarter 2022

Cision • 13 May 2022 07:00

Nordic Nanovector ASA: The Annual General Meeting held

Nordic Nanovector ASA: The Annual General Meeting held

Cision • 28 Apr 2022 17:11

Nordic Nanovector ASA: R&D Day to be virtual via live webcast only

Nordic Nanovector ASA: R&D Day to be virtual via live webcast only

Cision • 29 Nov 2021 08:00

Nordic Nanovector ASA: Invitation to attend R&D Day

Nordic Nanovector ASA: Invitation to attend R&D Day

Cision • 18 Nov 2021 07:04

Nordic Nanovector ASA: Results for the Third Quarter 2021

Nordic Nanovector ASA: Results for the Third Quarter 2021

Cision • 18 Nov 2021 07:01

Nordic Nanovector ASA: Resultat for tredje kvartal 2021

Nordic Nanovector ASA: Resultat for tredje kvartal 2021

Cision • 18 Nov 2021 07:00

Nordic Nanovector supports The Health Policy Partnership’s initiative to improve appropriate readiness for radioligand therapy (radioimmunotherapy) in lymphoma

Abstract by The Health Policy Partnership entitled “System-Level Barriers to Uptake of Existing and Novel Radioimmunotherapy for People with...

Cision • 09 Nov 2021 17:54

Nordic Nanovector ASA: Results for the Second Quarter and First Half 2021

Nordic Nanovector ASA: Results for the Second Quarter and First Half 2021

Cision • 27 Aug 2021 07:01

Nordic Nanovector ASA: Resultat for andre kvartal og første halvår 2021

Nordic Nanovector ASA: Resultat for andre kvartal og første halvår 2021

Cision • 27 Aug 2021 07:00

Nordic Nanovector ASA: Invitation to Second Quarter and First Half 2021 Results Presentation Webcast

Nordic Nanovector ASA: Invitation to Second Quarter and First Half 2021 Results Presentation Webcast

Cision • 20 Aug 2021 08:00